- Country: Ukraine
- Summary: Monoclonal Antibodies: Factor Viii -R Ag (Nc 024: 2023: 56077 - Factor Viii Closure: Rystocetin -Cofactor Activity
- UAT Ref No: 120881600
- Deadline: 21 Jun 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 500000
- Notice Type: Tender
- Document Ref. No.: UA-2025-06-13-006210-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Monoclonal antibodies: Factor VIII-R AG (NC 024: 2023: 56077-Factor VIII Closure in vitro), reagent; FOXL2 (NC 024: 2023: 54626 - NB antigen/70k human cancer IVD ovaries (diagnostics in vitro), reagent; actin (NC 024: 2023: 57581 - Actin of smooth muscle tissue IVD (diagnosis in vitro), antibodies; Steroidogenic Factor-1 (SF-1) (NC 024: 2023: 43743 Reagent for determining multiple steroid hormones, IVD (diagnostics in vitro); BCL-10 (NC 024: 2023: 56833 BCL-1 IVD. 5.2* (NK 024: 2023: 57079 - numerous cytokeratine filaments of high molecular weight IVD (diagnosis in vitro), antibodies); Cytokeratin, Pan (NC 024: 2023: 57074 - Pantoctioratic mixture of antibodies IVD (in vitro diagnosis), antibodies; PDX1 (NC 024: 2023: 54839 Numerous antibodies associated with myositis, IVD (diagnosis in vitro), reagent; Retinoblastoma (Rb) (NC 024: 2023: 59558 Congenital Retinoblastoma IVD (Diagnosis in Vitro), reagent; NUT (NC 024: 2023: 54839 Numerous antibodies associated with myoiasis, IVD (NAC) (NAC) 024: 2023: 57408 - Mesothelial cells IVD (diagnosis in vitro), antibodies); SOX -10 (NC 024: 2023: 57418 - a transcription factor associated with microfthalm IVD (in vitro diagnosis), antibodies; CD68 (NC 024: 2023: 57010 - CD68 cellular marker; 024: 2023: 57056 Type IVD type IV Collagen (in diagnosis in VI ...
Type of purchase: goods
DK 021: 2015: 33600000-6: Pharmaceutical products
Factor VIII-R AG, Foxl2, Actin, Steroidogenic Factor-1 (SF-1), BCL-10, CytoKeratin Cam 5.2*, Cytokeratin, Pan, PDX1, Retinoblastoma (RB), NUT, HBME-1, SOX-10, CD68, Kolagen Type IV, Insm1, Myoglobin, Cytakeratin 19, Cytakeratin 19 CD56, Galen-3 - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINMonoclonal Antibodies: Factor Viii -R Ag (Nc 024: 2023: 56077 - Factor Viii Closure: Rystocetin -Cofactor Activity - Ukraine Tender
The MUNICIPAL NON -COMMERCIAL ENTERPRISE "VINNYTSIA REGIONAL PATHOLOGICAL BUREAU OF VINNYTSIA REGIONAL COUNCIL, a Government sector organization in Ukraine, has announced a new tender for Monoclonal Antibodies: Factor Viii -R Ag (Nc 024: 2023: 56077 - Factor Viii Closure: Rystocetin -Cofactor Activity. This tender is published on UkraineTenders under UAT Ref No: 120881600 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-06-21.
The estimated tender value is UAH 500000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
